Losses widen at Isomorphic Labs, as new Nobel Prize winner pushes forward with effort to use AI in healthcare
Student story: An Executive MBA helped Joan LaRovere develop an AI tool to bring healthcare to ‘medical deserts’
Oxford university research comes as number of children treated by NHS mental health services surges
Drug company made claims even though a study of donanemab’s preventive potential is not due to end until 2027
Risk assessment by Food Standards Agency comes after FT investigation into impact of toxic metal
Awards for Sir Demis Hassabis, John Jumper and Geoffrey Hinton recognise how AI is changing our world
My every movement is being quantified, and I am obsessed
Agreement over heartburn medicine should help to resolve concerns hanging over UK drugmaker
Once an entertainment gimmick, the practice is becoming a powerful wellness tool
A record 35% of people aged 18-24 were classed as ‘inactive’ this year, driven by a mental health crisis
A bill in the Philippines is trying to secure time off for workers after a break-up. Could it improve productivity elsewhere?
It is too early to know whether the prompt response to the virus is enough to turn the tide
CBO analysis says savings from other health benefits would not offset expense of weight-loss jabs
Also in this newsletter: How greener corporate car fleets could boost competitiveness and the climate goals
US biotech researches treatments to reduce muscle loss from blockbuster diet medicines
Unsightly kerbside debris to some, eco-friendly cycles for hire have improved urban journeys
Weight loss drugs appear to be having an effect at the population level
From a Maldives villa with skateboard ramps, zip lines and bowling alley to an East Sussex barn conversion with a treetop play area
International collaboration plotted 149 metres of biological wiring in fruit fly
The company is thriving as weight-loss drugs boom, but investors see warning signs it has reached ‘peak enthusiasm’
Weight-loss drugs and a new focus on wellness are pushing many exercise machines towards obsolescence
New York City appointed a ‘rat tsar’ and launched ‘rat academies’ — its inaugural National Urban Rat Summit aimed to offer fresh insights to help landlords and renters
Artificial intelligence used to help researchers plan experiments and better predict outcomes
Drugmaker’s CEO sees chance to widen use of anti-obesity medications for ‘health maintenance’
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer
